2.20 USD
↘ 0.06 (2.44%)LIVE (AS OF 02:39 PM EDT)
Neumora Therapeutics, Inc. Common Stock
NMRANASDAQ • USD
Market: OPEN
Open?$2.25
High?$2.31
Low?$2.18
Prev. Close?$2.25
Volume?539.6K
Avg. Volume?1.2M
VWAP?$2.25
Rel. Volume?0.45x
Bid / Ask
Bid?$2.21 × 500
Ask?$2.22 × 1.1K
Spread?$0.01
Midpoint?$2.22
Valuation & Ratios
Market Cap?411.0M
Shares Out?182.7M
Float?68.3M
Float %?40.9%
P/E Ratio?N/A
P/B Ratio?3.96
EPS?-$1.30
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.87Strong
Quick Ratio?5.87Strong
Cash Ratio?5.62Strong
Debt/Equity?0.52Moderate
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?3.96FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-228.1%WEAK▾
ROA?-124.0%WEAK▾
Cash Flow & Enterprise
FCF?$-206456000
Enterprise Value?$283.1M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
Employees
96
Market Cap
411.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-09-15
Address
260 ARSENAL PLACE, SUITE 1
WATERTOWN, MA 02472
Phone: (857) 760-0900
WATERTOWN, MA 02472
Phone: (857) 760-0900